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Abstract: Cisplatin (Cis-diamminedichloroplatinum II, CP) is an important chemotherapeutic 
agent, useful in the treatment of several cancers, but with several side effects such as 
nephrotoxicity. The present study investigated the possible protective effect of selenium (Se) 
against CP-induced oxidative stress in the rat kidneys. Male Wistar  albino rats were 
injected with a single dose of cisplatin (7 mg CP/kg b.m., i.p.) and selenium (6 mg Se/kg 
b.m, as Na2SeO3, i.p.), alone or in combination. The obtained results showed that CP 
increased lipid peroxidation (LPO) and decreased reduced glutathione (GSH) 
concentrations, suggesting the CP-induced oxidative stress, while Se treatment reversed 
this change to control values. Acute intoxication of rats with CP was followed by 
statistically significant decreased activity of antioxidant defense enzymes: superoxide 
dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase 
(GR) and glutathione-S-transferase (GST). Treatment with Se reversed CP-induced 
alterations of antioxidant defense enzyme activities and significantly prevented the   
CP-induced kidney damage. 
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1. Introduction 
Cisplatin (cis-diammine-dichloroplatinum II, CP) has been considered one of the most effective 
chemotherapeutic agents, utilized for treatment of a variety of human solid tumors. Activity has been 
demonstrated against a variety of tumors, particularly of head and neck, ovarian, testicular, esophageal, 
bladder and small cell lung cancers [1]. The clinical use of CP is often limited due to its undesirable 
side effects, nephrotoxicity and neurotoxicity being the most severe and dose-limiting ones [2].   
CP-induced kidney damage is associated with increased kidney vascular resistance and histological 
damage to proximal tubular cells [1,3,4]. The cytotoxicity of CP
  is considered to be due to a 
combination of factors, including peroxidation of the cell membrane, mitochondrial dysfunction, 
inhibition of protein synthesis, and DNA injury [3,5,6]. The most common adverse effect limiting the
 
use of CP is nephrotoxicity that develops primarily
 in the S3 segment of the proximal tubule [7]. 
Although reactive
 oxygen species (ROS) have been considered to play a central
 role in this injury, the 
exact roles of free radicals and the mechanisms underlying the beneficial effects
 of free radical 
scavengers have not been fully evaluated [1–3,8,9]. 
The pathogenesis of kidney damage caused by CP is generally considered oxidative damage [1,2]. 
Administration of CP causes an increase in lipid peroxide levels and a decrease in the activity of 
antioxidant defense enzymes that prevent or protect from lipid peroxidation in the tissues. Cisplatin 
accumulates in the tubular epithelial cells of proximal kidney tubule, causing nephrotoxicity, 
characterized by morphological destruction of intracellular organelles, cellular necrosis, loss of 
microvilli, alterations in the number and size of the lysosomes and mitochondrial vacuolization, 
followed by functional alterations including inhibition of protein synthesis, GSH depletion, lipid 
peroxidation and mitochondrial damage [1,2,4,8–10].  
Recent studies have focused on the role of antoxidants in CP toxicity. The administration of 
antioxidants and other agents have been shown to ameliorate CP-induced toxicity in various species of 
animals [7,11–18].  
Selenium (Se) is an essential trace element which plays an important role in a number of biological 
processes in humans and many other forms of life. Many experimental studies of animals have 
demonstrated that the deficiency of Se induces some pathological conditions (coronary heart disease, 
liver necrosis) and is an important risk factor in the etiologies of these diseases [19–23]. Biological and 
medical advances in the area of Se provide interest in Se for both its antioxidant properties through 
seleno-enzyme incorporation and its direct pro-oxidant toxic effect through seleno-compounds [21,22]. 
Se is an essential component of several enzymes such as glutathione peroxidase (GSH-Px), thioredoxin 
reductase (TR) and selenoprotein P (SeP), which contains Se as selenocysteine. It is also well known 
that Se is essential for cell culture when a serum-free medium is used [21–25].  
Recent studies showed protective effects of Se against cadmium (Cd)-induced oxidative   
stress [26,27]. It has also been demonstrated that the chronic exposure to low levels of Cd and other 
toxic elements abolishes the cancer-protective effect of Se. An important property of Se is its Int. J. Mol. Sci. 2012, 13                
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interaction with other elements that may be present in food, water, at the workplace and in the 
environment. Se functions as an antagonist to the toxicity of metals such as Hg, Cd, As, Ag, Pb and  
Cu [28,29]. The arsenic-, platinum- and gold-containing drugs significantly influence the fate of 
exogenous Se, whereby they may adversely affect the availability of this element, essential for 
synthesis of selenoenzymes [30].  
The aim of the present study was to investigate a protective effect of Se pretreatment on lipid 
peroxidation (LPO) and reduced glutathione (GSH) concentrations and activity of antioxidant defense 
enzymes: superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione 
reductase (GR), as well as glutathione-S-transferase (GST) in the kidney of rats, acutely treated   
with CP. 
2. Experimental Methods 
2.1. Chemicals 
Cisplatin (cis-dichlorodiammine-platinum II, CP) and sodium selenite (Na2SeO3) were purchased 
from Merck Chemical Inc. (Darmstandt, Germany). Nicotinamide adenine dinucleotide phosphate 
(reduced form; NADPH); reduced (GSH) and oxidized (GSSG) glutathione; 1-chloro-2,4-dinitrobenzene 
(CDNB);  tert-butyl hydroperoxide (t BOOH); glutathione reductase; DTNB (5,5′-dithio-bis-2-
nitrobenzoic acid) and bovine serum albumin were purchased from Sigma Chemical Co. (St. Louis, 
MO, U.S.A). All other chemicals and reagents were of the highest commercially available purity. 
2.2. Animals and Treatments 
Male Wistar albino rats (about 3 months old, weighing 210–250 g) were used. The animals were 
kept under standard laboratory conditions (12 h light, 12 h dark and 21 ± 2 °C). All rats were housed in 
individual cages and given standard diet and tap water ad libitum. The University Committee of the 
Ethics of Animal Experimentation approved all animal experiments. The animals were divided into 
four groups (n = 6 per group) and treated as follows:  
Group 1: Control rats, treated intraperitoneally (i.p.) with isotonic saline. 
Group 2: Cisplatin (CP) (received i.p. a single dose of 7 mg CP/kg b.w.). 
Group 3: Selenium (Se) (received a single i.p. injection of Na2SeO3 in the dose of 6 mg Se/kg b.w.). 
Group 4: Se + CP (treated by Se 1 h before CP injection in the above mentioned amounts).  
After the treatment (3 days after CP injection) all animals were sacrificed by decapitation. The 
kidney tissues were quickly excised, rinsed in ice-cold saline and used immediately or stored frozen at 
−80 C until further biochemical analysis.  
2.3. Tissue Preparation 
The kidney tissues were minced and homogenized with a Thomas Sci Co. glass homogenizer 
(Teflon pestle) at 0–4 C (10% w/v) using 0.25 M sucrose, 1 mM EDTA and 0.05 M Tris-HCl solution 
and pH 7.4. The homogenates were centrifuged (90 min at 10,000× g, 4 C) and the supernatant was 
used for antioxidant defense enzyme activity assays and for total protein determination. Int. J. Mol. Sci. 2012, 13                
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2.4. Biochemical Analysis 
2.4.1. Lipid Peroxidation Assay 
Lipid peroxidation (LPO) was evaluated by measuring the MDA concentration. The tissues 
homogenates (using 1.15% KCl) were precipitated with trichloracetic acid. After centrifugation   
(1500× g, 15 min), the supernatant was mixed with TBA reagent (0.6%) and the mixture was kept at 
100 C for 1 h. The fluorescent reaction product was extracted with n-butanol and the fluorescence 
was measured in the organic phase, using a fluorescence spectrophotometer (excitation: 535 nm and 
emission: 555 nm) [31]. These results were expressed in nmol MDA/g tissue using a molar extinction 
coefficient for MDA of 1.56 × 10
5 M
−1·cm
−1. 
2.4.2. Determination of Antioxidant Enzyme Activity  
Superoxide dismutase (SOD, EC 1.15.1.1) activity was assayed in the supernatant by the 
epinephrine method [32]. The method is based on the measurement of the rate of epinephrine   
auto-oxidation inhibition by SOD contained in the examined samples in 50 mM sodium carbonate 
buffer pH 10.2, within the linear range of auto-oxidative curve. SOD activity was expressed as 
units/mg protein.  
Catalase (CAT, EC 1.11.1.6) activity was measured by the method of Beutler [33]. The method is 
based on the rate of H2O2 degradation by the action of CAT contained in the examined samples and 
followed spectrophotometrically at 230 nm in 5 mM EDTA, 1 M Tris-HCl solution, pH 8.0. The 
enzyme activity was expressed in μmol H2O2 min/mg protein. 
The activity of glutathione peroxidase (GSH-Px, EC 1.11.1.9) was determined using t-butyl 
hydroperoxide as a substrate by the method of Tamura et al. [34] and the activity was expressed as 
nmol NADPH oxidized/min/mg protein.  
Glutathione reductase (GR, EC 1.6.4.2) activity was assayed by the method of Glatzle et al. [35]  
by measuring NADPH oxidation in the presence of oxidized glutathione and the activity was expressed 
as nmol NADPH oxidized/min/mg protein.  
For determination of glutathione-S-transferase (GST, EC 2.5.1.18) activity, 1-chloro-2,4-dinitro 
benzene (CDNB) was used as a substrate [36] and the activity was expressed as nmol GSH used 
min/mg protein.  
2.4.3. Reduced Glutathione (GSH) Assay 
The concentration of reduced glutathione (GSH) was measured by the method of Beutler [37]. 
Tissue samples for GSH assay were homogenized on ice with 20 volumes of precipitating solution  
(1.5 mL 100 mmol/L Na-phosphate/5 mmol/L EDTA buffer, pH 8.0 and 0.4 mL 25% metaphosphoric 
acid) and then centrifuged at 10,000 g for 30 min at 4 °C. The reaction mixture contained   
0.5 mL of supernatant, 0.75 mL of Na-phosphate puffer (0.2 M, pH 7.4), 0.1 mL DTNB   
(5,5′-dithio-bis-2-nitrobenzoic acid) and 0.04 mL NaOH. The solution was kept at room temperature 
for 15 min and then read at 412 nm on a spectrophotometer. The concentration of GSH was expressed 
in μmol GSH/g protein.  Int. J. Mol. Sci. 2012, 13                
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2.4.4. Protein Concentration Assay 
The concentration of total proteins was determined by the biuret method [38] using Folin’s reagent 
and bovine serum albumin (BSA) as standard.  
2.5. Statistical Analysis 
All data are presented as means ± SD. Statistical significance of the results was evaluated by using 
one-way ANOVA (analysis of variance) test and post-comparison was carried out with Student’s t-test. 
A probability value less than 0.05 (p < 0.05) was considered statistically significant. 
3. Results  
The data presented in Tablе 1 show significant changes in the concentrations of LPO and GSH 
during the treatment of rats with CP and Se alone or in combination. The results showed that LPO 
concentration significantly increased in kidneys of rats treated with CP (by about 27%) (p < 0.05) in 
comparison to control. Pretreatment with Se was very effective in the prevention of oxidative damage 
induced by CP, which resulted in significantly lower LPO concentration. Alone Se treatment had 
showed no significant effect. Exposure to CP caused significant decrease of GSH concentration by 
25.6% (p < 0.05) in kidney of rats, while Se treatment reversed this change to control values. No 
significant change in GSH was found in rats treated with Se + CP and Se only in comparison with 
control group. 
Table 1. Effect of Se treatment on LPO and GSH concentrations in kidneys of CP-treated rats. 
Parameters 
Experimental groups 
Control  CP  Se  Se + CP 
LPO (nmol MDA/g tissue) 21.5 ± 2.8  27.3 ± 3.4 *  18.6 ± 1.5 
#  23.7 ± 2.3 
# 
GSH (μmol/g protein)  28.9 ± 3.8  21.5 ± 3.1 *  26.7 ± 2.7 
#  24.7 ± 2.7 
# 
Values are expressed as means ± SD; n = 6 for each treatment group; CP: Cisplatin; Se: selenium; 
LPO: lipid peroxidation; GSH: reduced glutathione; * p < 0.05 compared with control group,   
# p < 0.05 compared with CP group. 
Acute intoxication of rats with CP was followed by statistically significant decreased activities of 
all examined antioxidant defense enzymes (SOD, CAT, GSH-Px, GR and GST), (Figures 1–5). As 
represented in Figures 1 and 2, the exposure to CP caused the decrease of SOD and CAT activities (by 
about 37%) (p < 0.05) in kidney. In rats receiving Se only, and in rats pretreated with Se, the activities 
of SOD and CAT in kidney were similar to control values, but significantly increased (by about 21% 
and 26%) (p < 0.05) in comparison to the animals which received CP only.  Int. J. Mol. Sci. 2012, 13                
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Figure 1. Effect of Se treatment on superoxide dismutase (SOD) activity in kidney of  
CP-treated rats. Values are expressed as means ± SD; n = 6 for each treatment group;  
CP: Cisplatin; Se: selenium; * p < 0.05 compared with control group, # p < 0.05 compared 
with CP group. 
 
Figure 2. Effect of Se treatment on catalase (CAT) activity in kidney of CP-treated rats. 
Values are expressed as means ± SD; n  = 6 for each treatment group; CP: Cisplatin;   
Se: selenium; * p < 0.05 compared with control group, # p < 0.05 compared with CP group. 
 
Figure 3. Effect of Se treatment on glutathione peroxidase (GSH-Px) activity in kidney of 
CP-treated rats. Values are expressed as means ± SD; n = 6 for each treatment group;  
CP :Cisplatin; Se: selenium; * p < 0.05 compared with control group, # p < 0.05 compared 
with CP group. 
 Int. J. Mol. Sci. 2012, 13                
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Figure 4. Effect of Se treatment on glutathione reductase (GR) activity in kidney of   
CP-treated rats. Values are expressed as means ± SD; n = 6 for each treatment group;  
CP: Cisplatin; Se: selenium; * p < 0.05 compared with control group, # p < 0.05 compared 
with CP group. 
 
Figure 5. Effect of Se treatment on glutathione-S-transferase (GST) activity in kidney of 
CP-treated rats. Values are expressed as means ± SD; n = 6 for each treatment group;  
CP: Cisplatin; Se: selenium; * p < 0.05 compared with control group, # p < 0.05 compared 
with CP group. 
 
The exposure to CP caused a significant decrease of GSH-Px (by 32.1%), GR (by 23.2%) and GST 
(by 36.8%) activities in comparison to control group (p < 0.05), (Figures 3–5). The protective role of 
Se in acute CP intoxication resulted in increased activities of GSH-Px (by about 25%) (Figure 3), GR 
(by about 15%) (Figure 4) and GST (by about 31%) (Figure 5) when compared to the animals given 
CP alone. The presence of the antioxidants minimized the toxic effects of CP on the affected enzymes. 
Treatment with Se alone significantly increased GSH-Px activity in kidney in comparison to the 
control (by about 16%) and CP-treated groups (by about 48%). Administration of Se alone and/or in 
combination with CP did not cause significant changes in activity of GR and GST enzymes in 
comparison with control group. 
4. Discussion  
Cisplatin (CP), a heavy metal complex is one of the most active drugs used in the treatment of a 
variety of cancers. However, the clinical usefulness of this drug is limited due to the development of Int. J. Mol. Sci. 2012, 13                
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nephrotoxicity as a side effect that may be produced in various animal models [2,16,18]. The treatment 
of tumor cells with CP provokes several responses including membrane peroxidation, dysfunction of 
mitochondria, inhibition of protein synthesis and DNA damage [1,4–6,8–10]. The current study 
demonstrates that Se provides protection against CP-induced nephrotoxicity in rats. 
The data obtained in our study confirm that acute intoxication with CP causes a significant increase 
of LPO concentration in the kidney of rats (Table 1). CP-induced free radical production and LPO in 
tubular cells have been suggested to be responsible for the oxidative renal damage [1,3,8,14,39]. CP 
affects renal tissues where generated free radicals can interact with membrane lipids to produce their 
peroxidation, affecting cellular structure and function [2,17,18]. Kim et al. [12] observed that CP could 
promote the increase in lipid peroxidation in vitro. Pretreatment with Se was very effective in the 
prevention of oxidative damage induced by CP, which resulted in significantly lower LPO 
concentration in kidney. These results can be explained by the important role of Se in preventing lipid 
peroxidation and in protection of integrity and functioning of tissues and cells [13,20–23,26].  
Therapeutic effects of CP are based on the interaction with DNA in the cell, preventing 
proliferation, and inducing apoptosis in tumor cells. It was also observed that CP treatment increased 
BUN (blood urea nitrogen) and creatinine levels. A marked increase in BUN and creatinine in serum 
and histopathological changes including vacuolation, necrosis, and protein casts were observed in 
proximal renal tubules on the second day after CP injection in rats [3,5,6,39]. Mukhopadhyay et al. [40] 
observed that cisplatin-induced mitochondrial ROS generation triggered inflammatory response, cell 
death, and kidney dysfunction/nephropathy. Cisplatin initially triggers oxidative stress in the 
mitochondria of kidney proximal tubular and endothelial cells, which is followed by a secondary wave 
of ROS/RNS (reactive nitrogen species) generation, deterioration of mitochondrial structure and 
function, an intense inflammatory response, histopathological injury and diminished renal function. 
Inflammation may further amplify oxidative/nitrative stress, and these interrelated processes 
eventually culminate in more concerted renal tubular and endothelial cell demise (both apoptotic and 
necrotic), secondary hypoxia, kidney dysfunction, and failure [40]. A single systemic dose of 
mitochondrially targeted antioxidants, MitoQ or Mito-CP, dose-dependently, prevented cisplatin-
induced renal dysfunction. Mito-CP also prevented mitochondrial injury and dysfunction, renal 
inflammation, and tubular injury and apoptosis [40]. Recent studies showed protective effects of 
CoQ10 and Vit E against Cd-induced oxidative stress [41].  
A large number of natural products and dietary components have been evaluated as potential 
chemoprotective agents. Many experimental studies in animals have demonstrated the ability of Se to 
prevent carcinogenesis [23]. Supplementation of the antioxidant vitamin C, E, curcumin, Se and other 
dietary components has been reported to inhibit lipid peroxide in various conditions such as   
CP-induced nephrotoxicity and hepatotoxicity [12–18,39].  
In various studies that investigated the role of oxidant stress in the kidney, lipid peroxides are 
reported to be increased [13,14,16,18,39]. Enzymatic and non enzymatic antioxidant defense systems 
are present in the cell to prevent the integrity of biological membranes from oxidative processes 
caused by free radicals [42,43].  
The kidney antioxidant defense system, such as SOD, CAT, GSH-Px, GR, GST activities   
(Figures 1–5), and reduced GSH concentration (Table 1) significantly decreased in the CP alone 
treated group of animals compared to the control. CP generates ROS such as superoxide anion (O2
−) Int. J. Mol. Sci. 2012, 13                
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and hidroxil radicals (OH), and stimulates kidney lipid peroxidation [1,8,15,39,40]. It is accepted that 
both correlate to oxidative stress and cause the imbalance between the generation of oxygen derived 
radicals and the organism’s antioxidant potential [42,43]. CP-induced suppression of kidney antioxidant 
defense enzyme activity was also supported by the recently published experimental results [9,13,14].  
The decrease in SOD activity (Figure 1) after CP administration might be due to the loss of copper 
and zinc which are essential for the activity of enzyme or to ROS induced inactivation of enzyme 
proteins [13,18,39]. CP has been demonstrated to induce the loss of copper and zinc in the kidneys. 
The decreased SOD activity is insufficient to scavenge the superoxoide anion, produced during the 
normal metabolic process [42,43]. The activities of CAT and GSH-Px (Figures 2 and 3) were also 
found to decrease after CP administration, resulting in the decreased ability of the kidney to scavenge 
toxic hydrogen peroxide (H2O2) and lipid peroxides. CP administration resulted in a decline of GSH 
concentration (Table 1) and a decrease of GR and GST activities (Figures 4 and 5) in the rat kidney. 
The results from the present study indicate that Se significantly reduces the depletion of GSH 
concentration and antioxidant defense enzyme activity in the kidney of rat treated with CP. The 
protective effects of Se seem to be primarily associated with its presence in the GSH-Px, which is 
known to protect DNA and other cellular components from damage by ROS. Selenoenzymes are also 
known to play roles in carcinogen metabolism, in the control of cell division, oxygen metabolism, 
detoxification processes, apoptosis induction, and the functioning of the immune system [19–21,24,25]. 
GSH is necessary for resistance to oxidative stress through detoxification of ROS. It can also 
detoxify many endogenous toxins, including CP, through the formation of GSH adducts [7,17,44,45]. 
In addition, the GSH redox cycle, which includes GSH, GSH-Px and GR, plays an important role in 
the detoxification of ROS that are generated by CP, so as to protect cells from the potential toxicity 
and carcinogenesis [17,18,44,46]. The primary symptoms of cisplatin nephrotoxicity are inhibition of 
protein synthesis and intracellular GSH and protein-SH depletion, resulting in lipid peroxidation and 
mitochondrial damage [2,10,44,45]. GSH and protein-SH form the major cellular antioxidant defense 
systems, which control lipid peroxidation. The reduced renal GSH can markedly increase the toxicity 
of CP. The depletion of GSH also seems to be a prime factor that permits lipid peroxidation in the  
CP-treated group. The treatment with Se was very effective in the prevention of oxidative damage 
induced by CP, which resulted in significantly increased GSH concentration [47]. Experimental studies 
demonstrated that exogenous GSH could offer protection against CP-induced renal injury. Thiols, such 
as the sulfur of GSH, bind to the platinum molecule, replacing one of the chloride ions, thus preventing 
binding to other cellular nucleophiles [45]. The increased intracellular GSH concentration correlated 
with decreased platinum-DNA binding in freshly isolated peripheral blood mononuclear cells [6]. 
Studies of tumor cell lines have shown a correlation between the increased levels of intracellular GSH 
and the resistance to CP [44,45].  
GSH-Px, in particular, is highly dependent on GSH concentration. GSH-Px metabolizes H2O2 to 
water by using GSH as a hydrogen donor, resulting in the formation of GSSG [46,48]. GR
 subsequently 
regenerates GSH from GSSG.
 The decrease in the GSH-Px activity may result in the involvement of 
deleterious oxidative changes due to the accumulation of toxic products. The Se-containing enzyme 
GSH-Px protects cells against ROS. This result indicates that the increase in MDA in the kidney of rats 
treated with CP may be related to the decrease in the activity of GSH-Px. In this study, administration 
of Se exhibits GSH-Px-like activity, which prevented the decrease of GSH-Px activity in the kidney. Int. J. Mol. Sci. 2012, 13                
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Yoshida et al. [49] and Naziroğlu et al. [13] showed that the reduction of GSH-Px activity in the 
kidney tissue of rats treated with CP alone was prevented by co-treatment with Se.  
The GST enzyme has an important role in detoxification of xenobiotics, drugs, and carcinogens, 
thus protecting the cells against redox cycling and oxidative stress. The decrease in the GST activity or 
–SH group could explain the induction of free radicals in CP-treated rats [16]. GST is a family of 
enzymes that catalyzes the conjugation of GSH to a variety of substrates. Several isoforms of GST 
have been shown to bind CP in vivo [44,50]. In the studies where increased resistance to CP was 
observed, none determined whether the inactivation of CP was due to GST binding to the CP, or 
catalyzing its conjugation to GSH. The previous studies show that after incubation of blood platelets 
with CP, the amount of GSH decreased and the complex of cisplatin with GSH (GS-cisPt) was formed 
(via reaction catalysed by GST) [50,51]. Feinfeld et al. [52] and Badary et al. [16] showed that the rats 
given a single toxic dose of CP excreted detectable GST activity in their urine, thus suggesting that 
urinary GST activity was a marker for a CP-induced proximal tubular damage.  
The treatment with Se reversed the CP induced alterations of all examined parameters in rat kidney. 
The results indicate that Se significantly reduced the depletion of GSH concentration and antioxidant 
defense enzyme activity in the kidney of rats treated with CP, thus providing protection to the kidney. 
The protective effect of Se against CP-induced oxidative stress in this study could also be either direct, 
by inhibiting lipid peroxidation and scavenging free radicals [13,47], or indirect, through the 
enhancement of the activity of antioxidant defense enzymes including SOD, CAT and GSH-Px [9].  
Se can reduce the nephrotoxicity and hepatotoxicity of CP without reducing the antitumor activity 
of the drug [13,20]. The protection correlates with higher levels of Se in the kidney and with higher 
concentration of GSH in the kidney, both compared to tumors. Se is known to protect GSH by forming 
the selenodiglutathione complex [24]. It is known that substitution reactions with biologic nucleophiles 
appear to govern the antitumor and toxic properties of platinum complexes [53]. Selenite is 
metabolized into selenols, specifically into methylselenol and glutathionylselenol, while bioactivation 
of selenite into selenols is a GSH-dependent process. HPLC with on line radioactivity detection of 
195mPt showed that methylselenol (HSe-CH3) was capable of forming a complex with CP in vitro.  
1H-NMR gave evidence that the complex contained one or more Pt–Se–CH3 bonds. It is proposed that 
the formation of a CP-selenol complex also takes place in vivo, especially in the kidney, thereby 
preventing CP to exert its nephrotoxic activity [23,47]. The biological roles ascribed to Se include the 
prevention
 of cancer [19,54,55], cardiovascular disease and viral mutation [20–26,56].  
5. Conclusions  
In conclusion, we have shown that CP-induced nephrotoxicity is closely associated with the 
increase of lipid peroxidation in the kidney tissues. Treatment with CP causes significant changes in 
the activity of antioxidant defense enzymes (SOD, CAT, GSH-Px, GR and GST) and GSH 
concentration. The results of our study suggested that the treatment with Se reversed CP-induced lipid 
peroxidation and alterations in antioxidant defense system, and significantly prevented CP-induced 
kidneys damage. Our results showed that the nutritional antioxidant Se ameliorated oxidative stress 
and loss of cellular antioxidants and suggested that Se efficiently protected kidneys from CP-induced 
oxidative damage.  Int. J. Mol. Sci. 2012, 13                
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